IRIS International, Inc. manufactures automated in vitro diagnostic (IVD) products, sample processing products, and personalized diagnostics tests for use in hospitals and laboratories worldwide. It offers urinalysis and hematology products, including the family of iQ urine microscopy analyzers; the iChemVELOCITY urine chemistry analyzer; and development-stage products, such as 3GEMS urinalysis and hematology analyzers. The company also develops and markets sample processing products, such as small centrifuges, semi-automated DNA processing workstations, and sample processing consumables for specimen processing in medical institutions, commercial laboratories, clinics, doctors’ offices, veterinary laboratories, and research facilities. In addition, it offers personalized medicine products that consist of 510(k) cleared ProsVue prostate cancer test and other development-stage products that utilize its NADiA technology for ultra-sensitive detection of proteins for monitoring cancer and infectious disease applications. The company sells its products through a direct sales and service force in the United States, as well as through distributors internationally. IRIS International, Inc. was founded in 1979 and is headquartered in Chatsworth, California. IRIS International Inc. operates as a subsidiary of Danaher Corporation.